Skip to main content
Signal8
DENNER ALEXANDER J profile photo

Alexander J. Denner

CIK: 0001361754

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (31.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)11 (68.8%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

IRONWOOD PHARMACEUTICALS INC logo
IRWD

IRONWOOD PHARMACEUTICALS INC

Director
Innoviva, Inc. logo
INVA

Innoviva, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Sep 15, 2026
    Award(A)
    Direct
    3.7K shares-
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Jun 16, 2026
    Award(A)
    Direct
    63.5K shares-
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Jun 15, 2026
    Award(A)
    Direct
    4.1K shares-
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Mar 17, 2026
    Sale(S)
    Indirect
    6.7M shares at avg. $3.05$20.5M
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Mar 17, 2026
    Sale(S)
    Indirect
    5.8K shares at avg. $3.31$19K
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Mar 13, 2026
    Award(A)
    Direct
    4.5K shares-
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Dec 15, 2025
    Award(A)
    Direct
    4.2K shares-
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Sep 15, 2025
    Award(A)
    Direct
    11.7K shares-
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Jun 13, 2025
    Award(A)
    Direct
    24.2K shares-
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Jun 10, 2025
    Award(A)
    Direct
    45K shares-
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Apr 2, 2025
    Award(A)
    Direct
    10.4K shares-
  • Innoviva, Inc. logo
    INVA

    Innoviva, Inc.

    Mar 6, 2025
    Sale(S)
    Indirect
    1.2M shares at avg. $17.52$21.0M
  • Innoviva, Inc. logo
    INVA

    Innoviva, Inc.

    Mar 5, 2025
    Sale(S)
    Indirect
    270.4K shares at avg. $17.63$4.8M
  • Innoviva, Inc. logo
    INVA

    Innoviva, Inc.

    Mar 4, 2025
    Sale(S)
    Indirect
    151.2K shares at avg. $17.63$2.7M
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Dec 16, 2024
    Award(A)
    Direct
    4.2K shares-
  • IRONWOOD PHARMACEUTICALS INC logo
    IRWD

    IRONWOOD PHARMACEUTICALS INC

    Sep 16, 2024
    Award(A)
    Direct
    3.3K shares-

1-16 of 16

About DENNER ALEXANDER J

DENNER ALEXANDER J (SEC CIK 0001361754) files insider reports with the SEC as Director of IRONWOOD PHARMACEUTICALS INC (IRWD) and 10% Owner of Innoviva, Inc. (INVA).

Signal8 holds 12 ownership filings by DENNER ALEXANDER J, all Form 4s, filed between Sep 18, 2024 and Sep 17, 2026. Those filings report 16 transactions, from Sep 16, 2024 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DENNER ALEXANDER J's filings is in BOSTON, MA.

Recent filings by DENNER ALEXANDER J

  • Sep 15, 2026: Grant or award of IRWD shares (Form 4, code A).
  • Jun 16, 2026: Grant or award of IRWD shares (Form 4, code A).
  • Jun 15, 2026: Grant or award of IRWD shares (Form 4, code A).
  • Mar 17, 2026: Open-market sales of IRWD shares (2 lines, Form 4, code S).
  • Mar 13, 2026: Grant or award of IRWD shares (Form 4, code A).

Other insiders filing for IRONWOOD PHARMACEUTICALS INC (IRWD)

How to read Form 4 transaction codes